Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.79 HKD | -2.86% | -8.86% | +1.65% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Neutral |
Resistance | 7.450 | 7.750 | 9.890 |
Spread/Res. | -8.86% | -12.39% | -31.34% |
Spread/Supp. | +4.62% | +43.86% | +42.05% |
Support | 6.490 | 4.720 | 4.780 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 1477 Stock
- Charts Ocumension Therapeutics